A Prospective, Randomized, Double-Blind, Placebo-Controlled, Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A B, Live Cold-Adapted (CAIV-T) in Healthy Children Attending Day Care Centers.

Trial Profile

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A B, Live Cold-Adapted (CAIV-T) in Healthy Children Attending Day Care Centers.

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Apr 2009

At a glance

  • Drugs Influenza virus vaccine live (Primary)
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Sponsors MedImmune
  • Most Recent Events

    • 14 Apr 2009 Actual patient number (2903) added as reported by ClinicalTrials.gov.
    • 31 Oct 2006 Status change
    • 12 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top